UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of enkephalinergic systems in substance use disorders

Frontiers in systems neuroscience, 2022-08, Vol.16, p.932546-932546

2022

Volltextzugriff (PDF)

Delta Opioid Receptor Pharmacology and Therapeutic Applications

1st ed. 2018., 2018

Volltextzugriff (PDF)

Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders

Biomedicines, 2022-02, Vol.10 (2), p.398

2022

Volltextzugriff (PDF)

Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State

Molecular pharmacology, 2024-06, Vol.106 (1), p.47

2024

Volltextzugriff (PDF)

The Delta Opioid Receptor in Pain Control

Delta Opioid Receptor Pharmacology and Therapeutic Applications, 2018-01, Vol.247, p.147-177

2018

Volltextzugriff (PDF)

RGS inhibition at Gαi₂ selectively potentiates 5-HT1A-mediated antidepressant effects

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (24), p.11086-11091

2010

Volltextzugriff (PDF)

The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1

Molecular pharmacology, 2022-05, Vol.101 (5), p.371-380

2022

Volltextzugriff (PDF)

Mu opioid receptor (MOR) agonist‐induced antihyperalgesic effects following spared nerve injury in male and female rats

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Coincident Regulation of PLC β Signaling by Gq-Coupled and μ -Opioid Receptors Opposes Opioid-Mediated Antinociception

Molecular pharmacology, 2022-12, Vol.102 (6), p.269-279

2022

Volltextzugriff (PDF)

Multiple DSM‐5 substance use disorders: A national study of US adults

Human psychopharmacology, 2017-09, Vol.32 (5), p.n/a

2017

Volltextzugriff (PDF)

Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions

The Journal of pharmacology and experimental therapeutics, 2004-12, Vol.311 (3), p.1008

2004

Volltextzugriff (PDF)

Conditional ablation and recovery of forebrain neurogenesis in the mouse

Journal of comparative neurology (1911), 2009-06, Vol.514 (6), p.567-582

2009

Volltextzugriff (PDF)

Effects of Adolescent Δ9-Tetrahydrocannabinol Exposure on the Behavioral Effects of Cocaine in Adult Sprague-Dawley Rats

Experimental and clinical psychopharmacology, 2019-08, Vol.27 (4), p.326-337

2019

Volltextzugriff (PDF)

The Effects of Activation and Blockade of Delta Opioid Receptors on the Acquisition of Responding for an Opioid‐Associated Stimulus

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats

Pharmacology, biochemistry and behavior, 2011-10, Vol.99 (4), p.552-556

2011

Volltextzugriff (PDF)

5-Hydroxytryptophan Attenuates Somatic Signs of Nicotine Withdrawal

Journal of Pharmacological Sciences, 2011, Vol.117(2), pp.121-124

2011

Volltextzugriff (PDF)

The Roles of Opioid Receptors in Cutaneous Wound Healing

Delta Opioid Receptor Pharmacology and Therapeutic Applications, 2018-01, Vol.247, p.335-345

2018

Volltextzugriff (PDF)

Effects of food restriction on the conditioned reinforcing properties of an opioid-associated stimulus

Behavioural pharmacology, 2021-09, Vol.32 (6), p.505-514

2021

Volltextzugriff (PDF)

Multifunctional Opioid Ligands

Delta Opioid Receptor Pharmacology and Therapeutic Applications, 2018, Vol.247, p.21-51

2018

Volltextzugriff (PDF)

Tolerance to high‐internalizing δ opioid receptor agonist is critically mediated by arrestin 2

British journal of pharmacology, 2018-07, Vol.175 (14), p.3050-3059

2018

Volltextzugriff (PDF)

The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl- d-aspartate receptors

Neuropharmacology, 2011-06, Vol.60 (7), p.1126-1134

2011

Volltextzugriff (PDF)

The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats

Psychopharmacologia, 2005-07, Vol.180 (2), p.215-223

2005

Volltextzugriff (PDF)

Comparison of the muscarinic antagonist effects of scopolamine and L-687,306

Behavioural pharmacology, 2020-06, Vol.31 (4), p.359-367

2020

Volltextzugriff (PDF)

Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80

British journal of pharmacology, 2018-03, Vol.175 (6), p.891-901

2018

Volltextzugriff (PDF)

Effects of dose on acquisition and persistence of a new response for a remifentanil-associated stimulus

Behavioural pharmacology, 2020-04, Vol.31 (2&3), p.207-215

2020

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(116)

Publikationsform

Sprache

Englisch
(134)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(78)
Life Sciences & Biomedicine
(77)
Science & Technology
(77)
Pharmacology & Pharmacy
(66)
Male
(49)
Rats
(39)
Neurosciences
(35)
Rats, Sprague-Dawley
(33)
Neurosciences & Neurology
(32)
Humans
(29)
Dose-Response Relationship, Drug
(26)
Mice
(22)
Receptors, Opioid, Delta - Agonists
(20)
Psychiatry
(18)
Toxicology
(18)
Piperazines - Pharmacology
(17)
Analgesics, Opioid - Pharmacology
(16)
Behavior, Animal - Drug Effects
(15)
Benzamides - Pharmacology
(15)
Biological And Medical Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of enkephalinergic systems in substance use disorders

Delta Opioid Receptor Pharmacology and Therapeutic Applications

Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders

Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State

The Delta Opioid Receptor in Pain Control

RGS inhibition at Gαi₂ selectively potentiates 5-HT1A-mediated antidepressant effects

The Synthetic Cannabinoid WIN55,212-2 Can Disrupt the Golgi Apparatus Independent of Cannabinoid Receptor-1

Mu opioid receptor (MOR) agonist‐induced antihyperalgesic effects following spared nerve injury in male and female rats

Coincident Regulation of PLC β Signaling by Gq-Coupled and μ -Opioid Receptors Opposes Opioid-Mediated Antinociception

Multiple DSM‐5 substance use disorders: A national study of US adults

Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions

Conditional ablation and recovery of forebrain neurogenesis in the mouse

Effects of Adolescent Δ9-Tetrahydrocannabinol Exposure on the Behavioral Effects of Cocaine in Adult Sprague-Dawley Rats

The Effects of Activation and Blockade of Delta Opioid Receptors on the Acquisition of Responding for an Opioid‐Associated Stimulus

Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats

5-Hydroxytryptophan Attenuates Somatic Signs of Nicotine Withdrawal

The Roles of Opioid Receptors in Cutaneous Wound Healing

Effects of food restriction on the conditioned reinforcing properties of an opioid-associated stimulus

Multifunctional Opioid Ligands

Tolerance to high‐internalizing δ opioid receptor agonist is critically mediated by arrestin 2

The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl- d-aspartate receptors

The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats

Comparison of the muscarinic antagonist effects of scopolamine and L-687,306

Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80

Effects of dose on acquisition and persistence of a new response for a remifentanil-associated stimulus

Suchergebnisse filtern